Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

IoT Devices Put Your Security at Risk

There appears to be a growing problem of security threat…
Read more

Petition for EU to Ban Biometric Surveillance

A coalition consisting of both civil and digital rights groups…
Read more

Israel Strikes Iranian Targets in Syria

Israel reportedly bombed some Iranian targets in Syria late…
Read more